These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30612533)

  • 21. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders.
    Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Green JA
    Am J Vet Res; 2008 Aug; 69(8):1073-8. PubMed ID: 18672973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urothelial Carcinomas of the Urinary Bladder With Plasmacytoid or Rhabdoid Features and Tendency of Epithelial-Mesenchymal Transition in 3 Dogs.
    Lin SJ; Kao CF; Wang FI; Jeng CR; Lee JJ; Wang LY; Chang HW; Chen YJ; Liu CH; Pang VF
    Vet Pathol; 2018 Sep; 55(5):673-677. PubMed ID: 29661121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoxygenase-5 Expression in Canine Urinary Bladder: Normal Urothelium, Cystitis and Transitional Cell Carcinoma.
    Finotello R; Schiavo L; Ressel L; Frohmader A; Silvestrini P; Verin R
    J Comp Pathol; 2019 Jul; 170():1-9. PubMed ID: 31375151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques.
    Nedjadi T; Al-Maghrabi J; Assidi M; Dallol A; Al-Kattabi H; Chaudhary A; Al-Sayyad A; Al-Ammari A; Abuzenadah A; Buhmeida A; Al-Qahtani M
    BMC Cancer; 2016 Aug; 16():653. PubMed ID: 27539085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy.
    Kolla SB; Seth A; Singh MK; Gupta NP; Hemal AK; Dogra PN; Kumar R
    Int Urol Nephrol; 2008; 40(2):321-7. PubMed ID: 17899426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of epithelial and mesenchymal cell markers in canine urinary bladder transitional cell carcinoma.
    Shinada M; Saeki K; Yoshitake R; Eto S; Tsuboi M; Chambers JK; Uchida K; Kato D; Yoshimoto S; Kamoto S; Ikeda N; Kinoshita R; Fujita N; Nishimura R; Nakagawa T
    Vet J; 2020 Dec; 266():105571. PubMed ID: 33323173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of HER-2 via immunohistochemistry in canine urinary bladder transitional cell carcinoma - A marker of malignancy and possible therapeutic target.
    Millanta F; Impellizeri J; McSherry L; Rocchigiani G; Aurisicchio L; Lubas G
    Vet Comp Oncol; 2018 Jun; 16(2):297-300. PubMed ID: 28871659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superiority of fluorescent in situ hybridization over immunohistochemistry in detection of HER2 gene in carcinoma of the urinary bladder associated with and without schistosomiasis.
    Hammam O; Wishahi M; Hindawi A; Mosaad M; Akl M; Khalil H; Al Ganzoury H; Badawy M; Elesaily K
    J Egypt Soc Parasitol; 2014 Dec; 44(3):719-31. PubMed ID: 25643513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of tyrosine kinase receptors HER2, EGFR, and VEGFR expression in micropapillary urothelial carcinoma with invasive urothelial carcinoma.
    Li J; Jackson CL; Yang D; Noble L; Wheeler M; MacKenzie D; Adegun T; Amin A
    Target Oncol; 2015 Sep; 10(3):355-63. PubMed ID: 25293577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?
    Gandour-Edwards R; Lara PN; Folkins AK; LaSalle JM; Beckett L; Li Y; Meyers FJ; DeVere-White R
    Cancer; 2002 Sep; 95(5):1009-15. PubMed ID: 12209684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of human epidermal growth factor receptor 2 overexpression in canine anal sac gland carcinoma.
    Yoshimoto S; Kato D; Kamoto S; Yamamoto K; Tsuboi M; Shinada M; Ikeda N; Tanaka Y; Yoshitake R; Eto S; Saeki K; Chambers JK; Kinoshita R; Uchida K; Nishimura R; Nakagawa T
    J Vet Med Sci; 2019 Jul; 81(7):1034-1039. PubMed ID: 31142682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Density of tumor-infiltrating granzyme B-positive cells predicts favorable prognosis in dogs with transitional cell carcinoma.
    Inoue A; Maeda S; Kinoshita R; Tsuboi M; Yonezawa T; Matsuki N
    Vet Immunol Immunopathol; 2017 Aug; 190():53-56. PubMed ID: 28778323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exfoliative cytology of the canine urinary bladder: a technique utilising Millipore filtration.
    Rozengurt N; Hyman WJ; Berry A; Cooper JE; Wedderburn N
    Vet Rec; 1985 Apr; 116(15):414-5. PubMed ID: 4002563
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
    Junttila TT; Laato M; Vahlberg T; Söderström KO; Visakorpi T; Isola J; Elenius K
    Clin Cancer Res; 2003 Nov; 9(14):5346-57. PubMed ID: 14614020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].
    Wülfing C; von Struensee D; Bierer S; Bögemann M; Hertle L; Eltze E
    Aktuelle Urol; 2005 Sep; 36(5):423-9. PubMed ID: 16163605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphatic invasion is a significant indicator of poor patient outcome in canine bladder urothelial carcinoma.
    Govoni VM; Pigoli C; Sueiro FAR; Zuliani F; da Silva TO; Quitzan JG; Laufer-Amorim R; Grieco V; Fonseca-Alves CE
    Open Vet J; 2021; 11(4):535-543. PubMed ID: 35070848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaginal swab cytology as a diagnostic tool for neoplasia of the lower urinary tract in 5 dogs.
    Kao S; Barger A; Garrett LD
    Can Vet J; 2022 Dec; 63(12):1221-1225. PubMed ID: 36467378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNMT1: an emerging target in the treatment of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Hahn NM; Waddell J; Olbricht GR; Zheng R; Stewart JC; Knapp DW
    Urol Oncol; 2013 Nov; 31(8):1761-9. PubMed ID: 22609058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma.
    Isharwal S; Huang H; Nanjangud G; Audenet F; Chen YB; Gopalan A; Fine SW; Tickoo SK; Lee BH; Iyer G; Chadalavada K; Rosenberg JE; Bajorin DF; Herr HW; Donat SM; Dalbagni G; Bochner BH; Solit DB; Reuter VE; Al-Ahmadie HA
    Hum Pathol; 2018 Jul; 77():63-69. PubMed ID: 29601842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reason for euthanasia in dogs with urothelial carcinoma treated with chemotherapy or radiation therapy or both: A retrospective observational study.
    McKenna C; Poirier VJ; Oblak ML; Nykamp S; Mutsaers AJ
    J Vet Intern Med; 2024; 38(2):1127-1134. PubMed ID: 38317542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.